Top 10 Pharma CEO salaries of 2009

Welcome to to our annual look at the biggest CEO paychecks in the pharma industry. The major trend  in 2009 was the mega-merger, which helped propel former Schering-Plough CEO Fred Hassan to the top of this year's list. With the help of a $33 million golden handshake, Hassan bypassed perennial top dogs Bill Weldon (Johnson & Johnson) and Miles White (Abbott) as the highest-paid CEO in Pharma.

Novartis' Daniel Vasella moved up three places to the number four spot this year, but it will be his last appearance on our CEO pay list. Vasella stepped down as chief of Novartis in January, and was replaced by Joe Jimenez. To discover more details for yourself--or to find out what your boss is making--take a look at the list below.

1. Fred Hassan - Schering-Plough - $49.65M

2. Bill Weldon - Johnson & Johnson - $30M

3. Miles White - Abbott Laboratories - $26.2M

4. John Lechleiter - Eli Lilly - $20.9M

5. Daniel Vasella - Novartis - $20.24M

6. Jim Cornelius - Bristol-Myers Squibb - $18.2M

7. Richard Clark - Merck - $16.8M

8. Robert Coury - Mylan - $16M

9. Jeffrey Kindler - Pfizer - $14.8M

10. Frank Baldino - Cephalon - $11.1M

Top 10 Pharma CEO salaries of 2009

Suggested Articles

Today, AmerisourceBergen kicked off its first-ever ThinkLive Trade virtual event, a three-day online summit geared toward manufacturers.

With interim data for its COVID-19 vaccine still in the works, Pfizer is holding on to hope that it can still roll the shot out this year in the U.S.

While Eli Lilly has reasons to be excited about the future, one key medicine lagged expectations during the third quarter.